正海生物：钙硅生物陶瓷骨修复材料目前处于注册发补阶段

Core Viewpoint - Zhenghai Biological (300653) announced on August 6 that its calcium silicate bioceramic bone repair material is currently in the registration supplement phase, with an expected approval for the registration certificate by the end of 2025 [1] Group 1: Product Details - The calcium silicate bioceramic bone repair material is a calcium silicate-based product that promotes osteogenic differentiation and vascularization through silicon ions, effectively guiding the repair and regeneration of alveolar bone [1] - The product utilizes 3D printing technology to achieve a porous structure similar to autologous bone, providing an excellent osteogenic environment for tissue [1] - This product has the potential for customized production to meet patient-specific needs [1]